Intellectual Property Rights and Vaccines Promoting R&D and Production in Developing Countries, 16-17 November 2009, Tokyo, Japan
Presentations:
Session 1: Intellectual property rights and vaccines
- Antony Taubman
- Vaccines and Intellectual Property: Setting the Stage (Warren Kaplan)
- IP barriers to basic vaccines pneumonia and influenza (Martin Friede)
Session 2: Accessing IP and patent information
- Patent Landscapes; Shona McDiarmid
- Antony Taubman
- Patent Landscape of H5N1 Influenza Virus; Martin Friede
Session 3: Understanding patent information
- Understanding Patent Information: Claim Construction in the United States; Daniel Ravicher
- Rita Khanna
Session 4: Technology transfer for vaccine development and production in developing countries
- Improving Access to Medicines in Developing Countries through Local Production and Related Technology Transfer; Gina Vea
- Technology Transfer for Vaccine Development and Production in Developing Countries; Anthony So
- Case study 4 Netherlands Vaccine Institute (NVI); Jan Hendriks
Session 5: Licensing of IP for development and production of vaccines in developing countries
- Licensing of IP for Development and Production of Vaccines in Developing Countries; Curt Malloy
- Licensing of IP for Development and Production of Vaccines in Developing Countries; Anthony So
Session 6: Patent opposition
- Patent Challenges in India and Beyond; Chan Park
- Patent Opposition: United States; Daniel Ravicher
- Patent Opposition: United States; Gina Vea